News
Alzheimer’s blood test promises detection years before symptoms develop
February 1, 2018 /
Amyloid beta deposits, or plaques, in the brain are the most commonly hypothesized causative agent behind Alzheimer’s disease. A new breakthrough blood test, developed by an international team of scientists, can reportedly measure the concentration of these amyloid beta concentrations using just a tiny blood sample.
Rich Haridy
MATR Supporters (view all)
Posted in: Incubators and R&D
Sorry, we couldn't find any posts. Please try a different search.